Neuropeptide SF (human)
Discontinued ProductNeuropeptide SF (human) (Cat. No. 1886) has been withdrawn from sale for commercial reasons.
Endogenous antiopioid peptide, implicated in pain modulation and endocrine functions. Potently activates the orphan G-protein-coupled receptor HLWAR77 (NPFF2) (EC50 = 0.39 nM).
(Modifications: Phe-11 = C-terminal amide)
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Elshourbagy et al (2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J.Biol.Chem. 275 25965 PMID: 10851242
View Related Products by Target
Keywords: Neuropeptide SF (human), Neuropeptide SF (human) supplier, Implicated, pain, modulation, Anti-opioids, NPFF, Receptors, Neuropeptides, FF/AF, HLWAR77, NPFFR2, NeuropeptideSF, (human), npff2, neuropeptide, Neuropeptide, (human, FMRFamide-related), Miscellaneous/Non-selective, Opioids, 1886, Tocris Bioscience
Citations for Neuropeptide SF (human)
Citations are publications that use Tocris products.
Currently there are no citations for Neuropeptide SF (human).
Reviews for Neuropeptide SF (human)
There are currently no reviews for this product. Be the first to review Neuropeptide SF (human) and earn rewards!
Have you used Neuropeptide SF (human)?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.